Who is Centrexion Therapeutics Corp?

.--% Centrexion Therapeutics Corp is a late clinical-stage biopharmaceutical company. The Company is focused on identifying, developing and commercializing therapies to address the unmet medical need for the treatment of chronic pain. Its product candidate pipeline includes CNTX-4957, CNTX-0290, CNTX-6970, CNTX-2022 and CNTX-6016.

How much did Centrexion Therapeutics receive in its first tranche?

Analyst Reco. As of June 8, 2022, the company has received $62,500 in its first tranche. The transaction included participation from 25 investors. Centrexion Therapeutics Corporation announced that it has received $29.14 million in fu.. Centrexion Therapeutics Corporation announced that it has received $16.475 million in f..

Where is cntx headquartered?

The company was founded by Martin Lehr and Felix Kim in April 2015 and is headquartered in Philadelphia, PA. CNTX | Complete Context Therapeutics Inc. stock news by MarketWatch. View real-time stock prices and stock quotes for a full financial overview.